Incidence and mortality from prostate cancer were rising in most countries until the late 1980s. Following a number of advances in the management of prostate cancer, including introduction of the prostate-specific antigen (PSA) test, there have been reports of declines in mortality in Canada, the Un
International trends in prostatic cancer
β Scribed by David G. Zaridze; Peter Boyle; Michel Smans
- Book ID
- 102864906
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- French
- Weight
- 681 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The most m e n t data available demonstrate a 120-fold difference between the lowest and highest incidence rates of prostatic cancer, the disease being very common in North America, particularly among Blacks, and in Scandinavia, while it is rare in Japan and other oriental countries. The highest mortality for prostatic cancer is reported from St. Vincent and Grenadines, Martinique and Bermuda, from countries where the morbidity statistics are not available; the mortality rates reported from the United States and Canada are considerably lower. The incidence of and mortality from prostatic cancer have increased in most countries, in particular in areas with an initially low frequency of this disease. The ratio of mortality to incidence for prostatic cancer varies rather widely, being low in North America, Hawaii and Scandinavia. It is suggested that the observed variation in the mortality to incidence ratio for prostatic cancer could be due to differences in diagnostic practices between countries. This could explain, at least in part, the fact that the increasing trends of prostatic cancer incidence in North America are not w o mpanied by an increase in mortality from this tumour. This notion, however, does not exclude advances in treatment
π SIMILAR VOLUMES
## BACKGROUND. In Mexico, prostate cancer (PC) is the second highest cause of mortality by cancer in men. In 1991, there were 2,473 deaths, with a crude rate of 5.66 cases per 100,000 men age 40 or over. For this same year, the ratio of proportional mortality to the total number of malignant tumor